Lauren Sullivan, Member of the Firm, will present “Car-T/Cell and Gene Therapy Formulary Design — How to Find Value and Pay for Curative Therapies” at CBI’s Formulary and Access 2020 virtual event, which runs from July 27 to 30.
New innovative therapies in the pipeline could fundamentally change the way that diseases are treated, including curative abilities. This session highlights the evolution that needs to take place and the market access challenges that need to be overcome as the future becomes a reality. Topics will include how access and cost can be managed and the importance in the shift in benefit plan design.
For more information, visit CBINet.com.